Multiple Institutions Give AIM a "Buy" RatingHONG KONG SAR - Media OutReach Newswire – 5 February 2025 - AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to...
HONG KONG SAR - Media OutReach - 11 July 2023 - Halekulani Okinawa (Address: 1967-1, Nakama, Onna-son, Kunigami-gun, Okinawa, Japan; Manager: Jun Yoshie)...